ABT-737 is a useful component of combinatory chemotherapies for chronic myelogenous leukemias with diverse drug resistance mechanisms
- Author(s)
- Kuroda, J; Kimura, S; Andreeff, M; Ashihara, E; Kamitsuji, Y; Strasser, A; Taniwaki, M; Maekawa, T;
- Details
- Publication Year 2007-11-16,Volume 110,Issue #11,Page 248A-248A
- Journal Title
- BLOOD
- Publication Type
- Journal Article
- Publisher
- AMER SOC HEMATOLOGY
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2007-11-16 12:00:00